News from the CMSC Annual Meeting 2015
This month we are reporting from the 2015 Annual Meeting of the Consortium of Multiple Sclerosis Centers (CMSC) that took place on May 27-30 in Indianapolis, we have summarized the following lectures for you:
MRI advances in spinal cord offer deeper understanding of MS by Omar Khan, MD, director of the Sastry Foundation Advanced Imaging Laboratory at Wayne State University in Detroit.
Nurses offer line of defense in MS nonadherence by Megan Weigel, DNP, ARNP-C, MSCN of Baptist Neurology in Jacksonville Beach, FL.
MRI can help or hinder treatment of MS by Jill Conway, MD, of the Carolinas HealthCare System in Charlotte, NC.
CMSC symposium weighs factors in choosing between MS therapies, symposium held by Stephen Krieger, MD, of Mount Sinai Medical Center in New York, Jacqueline Bernard, MD, of the University of Chicago, Marie Namey, APRN, MSCN, of the Mellen Center for MS Treatment & Research in Cleveland, Michael Racke, MD, of Ohio State University.
Best practices offer guidance on treating MS in an evolving landscape by Corey Ford, MD, of the Multiple Sclerosis Specialty Clinic at the University of New Mexico.
Novel serum autoantibodies against talin1 in multiple sclerosis: Possible pathogenetic roles of the antibodies
Mayumi Muto, Masahiro Mori, Takaki Hiwasa, Masaki Takiguchi, Yasuo Iwadate, et al.Journal of Neuroimmunology (Available online 6 May 2015)
The role of laquinimod in modulation of the immune response in relapsing–remitting multiple sclerosis: Lessons from gene expression signatures
R. Zilkha-Falb, M. Gurevich, L. Hayardeny, A. AchironJournal of Neuroimmunology, Volume 283, 15 June 2015, Pages 11-16
Milos Kostic, Ivana Stojanovic, Goran Marjanovic, Nikola Zivkovic, Ana Cvetanovic
Cellular Immunology (Available online 28 April 2015)
Metabolic gene expression changes in astrocytes in Multiple Sclerosis cerebral cortex are indicative of immune-mediated signaling
T. Zeis, I. Allaman, M. Gentner, K. Schroder, J. Tschopp, et al.
Brain, Behavior, and Immunity (Available online 30 April 2015)
Treatment compliance with first line disease-modifying therapies in patients with multiple sclerosis. COMPLIANCE Study
A. Saiz, S. Mora, J. Blanco, for the COMPLIANCE Study investigators ◊ .
Neurología (English Edition), Volume 30, Issue 4, May 2015, Pages 214-222
About the Editors
- Timothy Vartanian, Professor at the Brain and Mind Research Institute and the Department of Neurology, Weill Cornell Medical College, Cornell...
- Claire S. Riley, MD is an assistant attending neurologist and assistant professor of neurology in the Neurological Institute, Columbia University,...
- Aug 201523Aug 201527
25th ISN Meeting & 13th APSNCairns, AustraliaThe International Society for Neurochemistry (ISN), founded in the 1960s, holds biennial meetings throughout the world, in conjunction with regional...
- Aug 201529Sep 20151Amsterdam, NetherlandsThe European College of Neuropsychopharmacology (ECNP) is a scientific association that provides a forum for the exchange and promotion of...